RIO DE JANEIRO, BRAZIL - Government and domestic private laboratory authorities involved in the production of vaccines against Covid-19 agree that the strategy to break patents of immunizers and medicines would have little impact on vaccination in the country. The alignment was expressed yesterday in a virtual public hearing held by the Senate.
The possible overturning of patents has provoked a clash between senators this week. Yesterday, the government and health sector technicians invited by the Temporary Commission of Covid-19 said that the country might not take advantage of the measure for not having a solid industrial base in . . .